Back to top
more

Zynex (ZYXI)

(Real Time Quote from BATS)

$8.28 USD

8.28
231,855

-0.65 (-7.28%)

Updated Jul 29, 2024 02:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ZYXI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Zynex Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 45 20 43 39 14
Receivables 27 35 29 14 6
Notes Receivable 0 0 0 0 0
Inventories 13 13 11 9 2
Other Current Assets 3 1 1 1 0
Total Current Assets 88 70 83 63 23
Net Property & Equipment 3 2 2 2 1
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 4 2 1 1 1
Intangibles 29 29 30 0 0
Deposits & Other Assets 0 1 1 0 0
Total Assets 137 116 133 72 28
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 8 6 5 5 2
Current Portion Long-Term Debt 0 5 5 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 6 6 4 3 2
Income Taxes Payable 1 2 2 0 0
Other Current Liabilities 0 0 4 0 0
Total Current Liabilities 19 21 23 10 5
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 58 0 0 0 0
Long-Term Debt 0 5 11 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 10 10 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 91 50 59 15 9
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 91 82 80 37 9
Retained Earnings 27 17 0 23 14
Other Equity 0 0 0 0 0
Treasury Stock 72 33 7 4 4
Total Shareholder's Equity 46 66 74 57 20
Total Liabilities & Shareholder's Equity 137 116 133 72 28
Total Common Equity 46 66 74 57 20
Shares Outstanding 33.90 37.40 38.20 38.20 36.00
Book Value Per Share 1.36 1.77 1.94 1.49 0.55

Fiscal Year End for Zynex Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 31 33 45 52 59
Receivables 24 25 27 33 33
Notes Receivable 0 0 0 0 0
Inventories 15 15 13 14 14
Other Current Assets 4 4 3 3 2
Total Current Assets 74 78 88 103 108
Net Property & Equipment 3 3 3 2 2
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 4 4 4 3 2
Intangibles 28 28 29 29 29
Deposits & Other Assets 0 0 0 0 1
Total Assets 122 126 137 151 153
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 8 10 8 8 6
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 6 7 6 7 6
Income Taxes Payable 0 1 1 2 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 18 22 19 20 14
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 58 58 58 57 0
Long-Term Debt 0 0 0 0 57
Non-Current Capital Leases 1 0 0 0 0
Other Non-Current Liabilities 0 0 0 7
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 89 93 91 93 90
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 92 91 91 91 83
Retained Earnings 28 27 27 26 22
Other Equity 0 0 0 0 0
Treasury Stock 87 85 72 58 43
Total Shareholder's Equity 33 33 46 59 62
Total Liabilities & Shareholder's Equity 122 126 137 151 153
Total Common Equity 33 33 46 59 62
Shares Outstanding 31.70 31.70 33.90 33.90 35.90
Book Value Per Share 1.04 1.04 1.36 1.73 1.73